VibroSense Dynamics strengthens the organization and signs a project agreement with Region Skåne and Lund University

VibroSense Dynamics strengthens the organization with a sale and marketing manager and an assistant project manager. The company has also signed a project agreement with Region Skåne and Lund University in the context of the parties' on-going Vinnova project. The agreement ensures that VibroSense receive exclusive rights to commercialize all research related to tactile biomarkers and normal materials.

The company's new Sales and Marketing manager begins after the summer. He will be a key figure in an effort to increase the sale of VibroSense hand instruments and to build up initial contacts to start clinical trials of the company's new foot device around the world. More information is presented when all concerned people are informed.

Michael Scarsén is appointed as assistant project manager and he begins in the company after the summer. Michael has previously been employed at VibroSense where he participated in the development of the company's current hand device, VibroSense Meter. Michael has also been involved in design and development of VibroSense prototype foot device. This ensures a fast ramp up of the development of the final product for examination and diagnostics of tactile sensitivity in feet. Michael has broad technical knowledge combined with a sense of order which is required in development of a commercial product, adopted for volume manufacturing.

- I'm very happy to have Michael back and since I've worked with him before, I know that it means a lot for the company. Now we get a strong team that both increases the company's expertise and secures product development, says Toni Speidel, CEO VibroSense Dynamics.

The agreement with Region Skåne and Lund University is part of the company’s so called Vinnova project. This project is a collaboration between three parties and it is extremely important that all rights and obligations are regulated early.

The Vinnova project will run for three years and a huge amount of data will be collected. All data obtained will be the basis for the software algorithms and reference levels embedded in the VibroSense software for the company's new foot and hand device.

- It is very important to ensure that you receive exclusive rights to commercialize the research results. Even though all parties verbally agreed to this from start, it feels extra comforting now when it also is agreed in writing, with a signed contract, says Toni Speidel, CEO VibroSense Dynamics.

About foot ulcers and the VibroSense Meter system
All people with diabetes, both type I and II, have increased risk of getting foot ulcers, which in the worst case lead to amputation of all or part of the foot. This complication is often unnecessary according to medical experts, provided that impaired sensitivity is detected early. For early detection, preventive measures can be initiated, which can prevent a great deal of suffering and reduce the costs significantly. In 2014 the health care costs related to diabetes was estimated to at least 612 billion dollars worldwide.

VibroSense Dynamic’s device, the VibroSense Meter, can detect loss of sensitivity in hands at a very early stage. Pilot studies on feet have shown very promising results, so good that the company will develop a new device for examination of feet utilizing Multi Frequency Vibrometry. The objective is that the development shall be completed latest at the second half of 2017.

The company's technology Multi Frequency Vibrometry is superior to other clinical method for assessment of tactile sensibility, available on the market today

Contact
Toni Speidel, CEO VibroSense Dynamics AB, 070-893 21:07, and info@vibrosense.se .
www.vibrosense.se

About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and markets medical devices and services for diagnostics of nerve damage in hands and feet to Diabetes clinics, Occupational health care, Hospitals, Clinics and Scientists. The company was founded in 2005 and has its headquarters in Malmö, Sweden.

Tags:

About Us

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms. The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands. www.vibrosense.com

Subscribe

Documents & Links